Vistin Pharma ASA (OSL:VISTN)

Norway flag Norway · Delayed Price · Currency is NOK
22.10
-0.30 (-1.34%)
At close: Mar 2, 2026
-8.68%
Market Cap 966.71M
Revenue (ttm) 452.29M
Net Income (ttm) 74.76M
Shares Out 44.34M
EPS (ttm) 1.69
PE Ratio 12.93
Forward PE n/a
Dividend 1.50 (6.79%)
Ex-Dividend Date n/a
Volume 4,853
Average Volume 19,623
Open 22.50
Previous Close 22.40
Day's Range 21.60 - 22.50
52-Week Range 19.40 - 27.30
Beta 0.64
RSI 54.23
Earnings Date Feb 12, 2026

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway. [Read more]

Sector Healthcare
Founded 1969
Employees 75
Stock Exchange Oslo Børs
Ticker Symbol VISTN
Full Company Profile

Financial Performance

In 2025, Vistin Pharma ASA's revenue was 452.29 million, an increase of 5.31% compared to the previous year's 429.50 million. Earnings were 74.76 million, an increase of 19.13%.

Financial Statements

News

There is no news available yet.